Advertisement

Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population

  • Rajani Rai
  • Kiran L. Sharma
  • Sanjeev Misra
  • Ashok Kumar
  • Balraj MittalEmail author
Original Article - Cancer Research

Abstract

Purpose

Gallbladder cancer (GBC), the most common gastrointestinal and biliary tract malignancy, often coincides with gallstone disease (GSD). The genetic variants of adrenergic receptor (ADR) have been previously reported to be associated with hypomotility disorder of cardiovascular system and GSD. Since GSD may function as GBC precursor, the present study aimed to investigate the association of common functional genetic variants of ADRA2A C-1291G, ADRβ3 T190C or Trp64Arg, and ADRβ1 C1165G or Arg389Gly with GBC and GSD susceptibility.

Methods

The present study included a total of 400 histologically confirmed GBC, 230 GSD, and 268 healthy controls. The ADRA2A C-1291G, ADRβ3 T190C, and ADRβ1 C1165G polymorphisms were determined by PCR–RFLP. Statistical analysis was performed by using SPSS version 16.

Results

ADRβ3 T190C polymorphism was significantly associated with increased risk of GBC (CT: Pcorr = 0.015, OR 2.87; CC: Pcorr = 0.038, OR 10.33; C allele: Pcorr = 0.014, OR 2.7; CT + CC: Pcorr = 0.017, OR 3.05). These associations existed even after gallstone and gender stratification. Similarly, ADRβ3 T190C polymorphism was also associated with GSD risk, though limited only to female GSD patients. In contrary, ADRA2A C-1291G conferred a marginally increased risk only in GSD patients. ADRβ1 C1165G polymorphism was not associated with GBC and GSD susceptibility when compared to controls.

Conclusion

ADRβ3 T190C polymorphism is significantly associated with GBC and GSD susceptibility. The ADRβ3 T190C may be involved in the pathophysiology of GBC by both gallstone-dependent pathway and by some other independent mechanisms.

Keywords

Adrenergic receptors (ADR) Gallbladder cancer (GBC) Gallstone disease (GSD) Single-nucleotide polymorphisms (SNP) Case–control study 

Abbreviations

GBC

Gallbladder cancer

ADR

Adrenergic receptors

HC

Healthy controls

GSD

Gallstone disease

SNP

Single-nucleotide polymorphism

SPSS

Statistical package for social sciences

FDR

False discovery rate

OR

Odds ratio

CI

Confidence interval

HWE

Hardy–Weinberg equilibrium

Notes

Acknowledgments

The authors thank Department of Biotechnology and Indian Council of Medical Research, Govt of India, for financial support to carry out the present study.

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

432_2014_1621_MOESM1_ESM.doc (128 kb)
Supplementary material 1 (DOC 128 kb)

References

  1. Anthony A, Schepelmann S, Guillaume JL et al (1998) Localization of the β(beta)3-adrenoceptor in the human gastrointestinal tract: an immunohistochemical study. Aliment Pharmacol Ther 12:519–525CrossRefPubMedGoogle Scholar
  2. Babol K, Blasiak J (2005) Beta3-adrenergic receptor. Postepy Biochem 51:80–87PubMedGoogle Scholar
  3. Babol K, Przybylowska K, Lukaszek M, Pertynski T, Blasiak J (2004) An association between the Trp64Arg polymorphism in the beta3-adrenergic receptor gene and endometrial cancer and obesity. J Exp Clin Cancer Res 23:669–674PubMedGoogle Scholar
  4. Bracale R, Pasanisi F, Labruna G et al (2007) Metabolic syndrome and ADRB3 gene polymorphism in severely obese patients from South Italy. Eur J Clin Nutr 61:1213–1219CrossRefPubMedGoogle Scholar
  5. Bristow MR, Ginsburg R, Umans V et al (1986) Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 59:297–309CrossRefPubMedGoogle Scholar
  6. Bylund DB (1992) Subtypes of alpha 1- and alpha 2-adrenergic receptors. FASEB J 6:832–839PubMedGoogle Scholar
  7. Chou YC, Tsai CN, Lee YS, Pei JS (2012) Association of adrenergic receptor gene polymorphisms with adolescent obesity in Taiwan. Pediatr Int 54:111–116CrossRefPubMedGoogle Scholar
  8. Chuang SC, Hsi E, Lee KT (2013) Genetics of gallstone disease. Adv Clin Chem 60:143–185CrossRefPubMedGoogle Scholar
  9. Cole SW, Sood AK (2012) Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res 18:1201–1206CrossRefPubMedGoogle Scholar
  10. Doggrell SA, Scott GW (1980) The occurrence of postsynaptic alpha- and beta-adrenoceptors in the guinea-pig gall bladder. Br J Pharmacol 71:185–189CrossRefPubMedPubMedCentralGoogle Scholar
  11. Everhart JE (1993) Contributions of obesity and weight loss to gallstone disease. Ann Intern Med 119:1029–1035CrossRefPubMedGoogle Scholar
  12. Forray C, Bard JA, Wetzel JM et al (1994) The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype. Mol Pharmacol 45:703–708PubMedGoogle Scholar
  13. Guillaume JL, Petitjean F, Haasemann M, Bianchi C, Eshdat Y, Strosberg AD (1994) Antibodies for the immunochemistry of the human beta 3-adrenergic receptor. Eur J Biochem 224:761–770CrossRefPubMedGoogle Scholar
  14. Hamdani NH, Qadri SK, Aggarwalla R et al (2012) Clinicopathological study of gall bladder carcinoma with special reference to gallstones: our 8-year experience from eastern India. Asian Pac J Cancer Prev 13:5613–5617CrossRefPubMedGoogle Scholar
  15. Hegele RA, Harris SB, Hanley AJ, Azouz H, Connelly PW, Zinman B (1998) Absence of association between genetic variation of the beta 3-adrenergic receptor and metabolic phenotypes in Oji-Cree. Diabetes Care 21:851–854CrossRefPubMedGoogle Scholar
  16. Huang XE, Hamajima N, Saito T et al (2001) Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer. Breast Cancer Res 3:264–269CrossRefPubMedPubMedCentralGoogle Scholar
  17. Kimura K, Sasaki N, Asano A et al (2000) Mutated human beta3-adrenergic receptor (Trp64Arg) lowers the response to beta3-adrenergic agonists in transfected 3T3-L1 preadipocytes. Horm Metab Res 32:91–96CrossRefPubMedGoogle Scholar
  18. Klass DM, Lauer N, Hay B, Kratzer W, Fuchs M (2007) Arg64 variant of the beta3-adrenergic receptor is associated with gallstone formation. Am J Gastroenterol 102:2482–2487CrossRefPubMedGoogle Scholar
  19. Kobilka B (1992) Adrenergic receptors as models for G protein-coupled receptors. Annu Rev Neurosci 15:87–114CrossRefPubMedGoogle Scholar
  20. Krief S, Lonnqvist F, Raimbault S et al (1993) Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest 91:344–349CrossRefPubMedPubMedCentralGoogle Scholar
  21. Kumar S, Mishra A, Srivastava A, Mittal T, Garg N, Mittal B (2014) Significant role of ADRB3 rs4994 towards the development of coronary artery disease. Coron Artery Dis 25:29–34CrossRefPubMedGoogle Scholar
  22. Lima JJ, Feng H, Duckworth L et al (2007) Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metabolism 56:757–765CrossRefPubMedPubMedCentralGoogle Scholar
  23. Liu ZQ, Mo W, Huang Q, Zhou HH (2007) Genetic polymorphisms of human beta-adrenergic receptor genes and their association with obesity. Zhong Nan Da Xue Xue Bao Yi Xue Ban 32:359–367PubMedGoogle Scholar
  24. Liu WN, Fu KL, Gao HY et al (2012) beta1 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to beta-blocker therapy and prognosis. PLoS ONE 7:e37659CrossRefPubMedPubMedCentralGoogle Scholar
  25. Mathur SK, Duhan A, Singh S et al (2012) Correlation of gallstone characteristics with mucosal changes in gall bladder. Trop Gastroenterol 33:39–44CrossRefPubMedGoogle Scholar
  26. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215CrossRefPubMedPubMedCentralGoogle Scholar
  27. Misra S, Chaturvedi A, Misra NC, Sharma ID (2003) Carcinoma of the gallbladder. Lancet Oncol 4:167–176CrossRefPubMedGoogle Scholar
  28. Oguri K, Tachi T, Matsuoka T (2013) Visceral fat accumulation and metabolic syndrome in children: the impact of Trp64Arg polymorphism of the beta3-adrenergic receptor gene. Acta Paediatr 102:613–619CrossRefPubMedGoogle Scholar
  29. Parkinson NA, Hughes AD (1995) The mechanism of action of alpha 2-adrenoceptors in human isolated subcutaneous resistance arteries. Br J Pharmacol 115:1463–1468CrossRefPubMedPubMedCentralGoogle Scholar
  30. Plummer HK, Yu Q, Cakir Y, Schuller HM (2004) Expression of inwardly rectifying potassium channels (GIRKs) and beta-adrenergic regulation of breast cancer cell lines. BMC Cancer 4:93CrossRefPubMedPubMedCentralGoogle Scholar
  31. Quoc Lu’o’ng KV, Nguyen LT (2012) The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signalling mechanisms. Cancer Manag Res 4:431–445PubMedPubMedCentralGoogle Scholar
  32. Rai R, Tewari M, Kumar M, Singh TB, Shukla HS (2011) Expression profile of cholecystokinin type-A receptor in gallbladder cancer and gallstone disease. Hepatobiliary Pancreat Dis Int 10:408–414CrossRefPubMedGoogle Scholar
  33. Rai R, Sharma KL, Misra S, Kumar A, Mittal B (2013) PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females. Gene 530:172–177CrossRefPubMedGoogle Scholar
  34. Rosmond R, Bouchard C, Bjorntorp P (2002) A C-1291G polymorphism in the alpha2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels. J Intern Med 251:252–257CrossRefPubMedGoogle Scholar
  35. Rudner XL, Berkowitz DE, Booth JV et al (1999) Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age. Circulation 100:2336–2343CrossRefPubMedGoogle Scholar
  36. Sahlin S, Granstrom L, Gustafsson U, Stahlberg D, Backman L, Einarsson K (1994) Hepatic esterification rate of cholesterol and biliary lipids in human obesity. J Lipid Res 35:484–490PubMedGoogle Scholar
  37. Schlesinger S, Aleksandrova K, Pischon T et al (2013) Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer 132:645–657CrossRefPubMedGoogle Scholar
  38. Seremak-Mrozikiewicz A, Drews K, Nowocien G, Kaluba-Skotarczak A, Boc A (2008) The significance of beta-3 adrenergic receptor polymorphism in excessive body gain and obesity development in pregnant women. Ginekol Pol 79:51–55PubMedGoogle Scholar
  39. Srivastava A, Pandey SN, Dixit M, Choudhuri G, Mittal B (2008) Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer. J Gastroenterol Hepatol 23:970–975CrossRefPubMedGoogle Scholar
  40. Srivastava A, Mishra A, Singh R, Rai R, Srivastava N, Mittal B (2013) Multi-analytic approach elucidates significant role of hormonal and hepatocanalicular transporter genetic variants in gallstone disease in North Indian population. PLoS ONE 8:e59173CrossRefPubMedPubMedCentralGoogle Scholar
  41. Strosberg AD (1993) Structure, function, and regulation of adrenergic receptors. Protein Sci 2:1198–1209CrossRefPubMedPubMedCentralGoogle Scholar
  42. Takeuchi S, Katoh T, Yamauchi T, Kuroda Y (2012) ADRB3 polymorphism associated with BMI gain in Japanese men. Exp Diabetes Res 2012:973561CrossRefPubMedPubMedCentralGoogle Scholar
  43. Takezaki T, Hamajima N, Matsuo K et al (2001) Association of polymorphisms in the beta-2 and beta-3 adrenoceptor genes with risk of colorectal cancer in Japanese. Int J Clin Oncol 6:117–122CrossRefPubMedGoogle Scholar
  44. Tsuchiya Y, Terao M, Okano K et al (2011) Mutagenicity and mutagens of the red chilli pepper as gallbladder cancer risk factor in Chilean women. Asian Pac J Cancer Prev 12:471–476PubMedGoogle Scholar
  45. Walston J, Silver K, Bogardus C et al (1995) Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med 333:343–347CrossRefPubMedGoogle Scholar
  46. Wang H, Liu J, Liu K et al (2013) Beta1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: a meta-analysis. Mol Biol Rep 40:4055–4063CrossRefPubMedGoogle Scholar
  47. Wenjuan Y, Yujun L, Ceng Y (2013) Association of single nucleotide polymorphisms of beta2-adrenergic receptor gene with clinicopathological features of pancreatic carcinoma. Acta Histochem 115:198–203CrossRefPubMedGoogle Scholar
  48. Wistuba II, Gazdar AF (2004) Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer 4:695–706CrossRefPubMedGoogle Scholar
  49. Xu HL, Hsing AW, Vogtmann E et al (2013) Variants in CCK and CCKAR genes to susceptibility to biliary tract cancers and stones: a population-based study in Shanghai, China. J Gastroenterol Hepatol 28:1476–1481CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Rajani Rai
    • 1
  • Kiran L. Sharma
    • 1
  • Sanjeev Misra
    • 2
  • Ashok Kumar
    • 3
  • Balraj Mittal
    • 1
    Email author
  1. 1.Department of GeneticsSanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS)LucknowIndia
  2. 2.Department of Surgical OncologyKGMULucknowIndia
  3. 3.Department of Surgical GastroenterologySanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS)LucknowIndia

Personalised recommendations